Linked Life Data

4015045

Source:http://linkedlifedata.com/resource/pubmed/id/4015045

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1985-8-5
pubmed:abstractText
Specific binding sites for the antiestrogen tamoxifen (AEBStot), as measured with the dextran-coated charcoal technique and Scatchard analysis, were quantitated in 43 of 44 breast cancer samples (41-2,100 fmol/mg protein). In this work, AEBStot has been defined as the sum of AEBSspec and estrogen receptor (ER), AEBSspec shows a very weak positive correlation with ER, and no correlation with progesterone receptor. Tamoxifen (TAM) has a lower affinity to ER compared with one of its main metabolites, 4-OH-TAM. This may be one reason why inhibition by excess estradiol on 3H-4-OH-TAM binding was better correlated with ER content in the same sample than if 3H-TAM was the radioactive ligand. It is therefore suggested that 3H-4-OH-TAM is a better choice than 3H-TAM for measuring AEBSspec alone. A possible role of AEBSspec for the clinical effects of TAM is discussed.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0250-7005
pubmed:author
pubmed:issnType
Print
pubmed:volume
5
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
307-12
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:articleTitle
Antiestrogen binding sites in human breast cancer biopsies. Measurement ligand-specificity and affinity, and correlation to estrogen and progesterone receptors.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't